Aehr Test System Reiterates H2 FY26 Guidance, Sees Revenue $25M-$30M, Adj EPS Loss $(0.09)-$(0.05).

Benzinga Newsdesk www.benzinga.com Neutral 52.6%

Neg 0% Neu 52.6% Pos 0%

Aehr Test System (NASDAQ:AEHR) reiterates H2 FY26 Guidance, Sees Revenue $25M-$30M, Adj EPS Loss $(0.09)-$(0.05).

Comments

No comments yet. Be the first!